These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 32945493

  • 1. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
    Wu CH, Yeh CT, Lin KH.
    Oncol Rep; 2020 Oct; 44(4):1686-1698. PubMed ID: 32945493
    [Abstract] [Full Text] [Related]

  • 2. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C, Liu D, Zhang Y, Lou G, Huang G, Chen B, Shen X, Gao M, Gong W, Zhou P, Dai S, Zeng Y, He F.
    Oncogene; 2014 May 29; 33(22):2888-97. PubMed ID: 23812424
    [Abstract] [Full Text] [Related]

  • 3. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G, Yan Z, Zhang C, Cheng M, Yan Y, Wang Y, Deng L, Lu Q, Luo S.
    J Exp Clin Cancer Res; 2019 May 09; 38(1):188. PubMed ID: 31072351
    [Abstract] [Full Text] [Related]

  • 4. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
    Park YH, Kim SU, Kwon TH, Kim JM, Song IS, Shin HJ, Lee BK, Bang DH, Lee SJ, Lee DS, Chang KT, Kim BY, Yu DY.
    Oncogene; 2016 Jul 07; 35(27):3503-13. PubMed ID: 26500057
    [Abstract] [Full Text] [Related]

  • 5. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
    Chai N, Xie HH, Yin JP, Sa KD, Guo Y, Wang M, Liu J, Zhang XF, Zhang X, Yin H, Nie YZ, Wu KC, Yang AG, Zhang R.
    Biochem Biophys Res Commun; 2018 Jun 12; 500(4):924-929. PubMed ID: 29705704
    [Abstract] [Full Text] [Related]

  • 6. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
    Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, De Miglio MR, Tomasi ML, Sanna V, Muroni MR, Feo F, Pascale RM.
    Gut; 2009 May 12; 58(5):679-87. PubMed ID: 19136513
    [Abstract] [Full Text] [Related]

  • 7. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
    Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC.
    J Pathol; 2017 Dec 12; 243(4):418-430. PubMed ID: 28862757
    [Abstract] [Full Text] [Related]

  • 8. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
    Tian C, Wu H, Li C, Tian X, Sun Y, Liu E, Liao X, Song W.
    Gene Ther; 2018 Jul 12; 25(4):312-319. PubMed ID: 29973656
    [Abstract] [Full Text] [Related]

  • 9. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
    Sun L, Wang Y, Wang L, Yao B, Chen T, Li Q, Liu Z, Liu R, Niu Y, Song T, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2019 Apr 18; 38(1):170. PubMed ID: 30999932
    [Abstract] [Full Text] [Related]

  • 10. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME, Pinna F, Wolf T, Lutz T, Geldiyev A, Sticht C, Knaub M, Thomann S, Bissinger M, Wan S, Rössler S, Becker D, Gretz N, Lang H, Bergmann F, Ustiyan V, Kalin TV, Singer S, Lee JS, Marquardt JU, Schirmacher P, Kalinichenko VV, Breuhahn K.
    Gastroenterology; 2017 Jun 18; 152(8):2037-2051.e22. PubMed ID: 28249813
    [Abstract] [Full Text] [Related]

  • 11. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
    Chi HC, Chen SL, Cheng YH, Lin TK, Tsai CY, Tsai MM, Lin YH, Huang YH, Lin KH.
    Cell Death Dis; 2016 Aug 04; 7(8):e2324. PubMed ID: 27490929
    [Abstract] [Full Text] [Related]

  • 13. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y, Wang H, Yan Z, Li G, Hu G, Zhang H, Huang D, Wang Y, Zhang X, Yan Y, Lu Q, Cheng M, Luo S.
    Cell Commun Signal; 2020 Jul 28; 18(1):116. PubMed ID: 32723329
    [Abstract] [Full Text] [Related]

  • 14. Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.
    Chand V, Pandey A, Kopanja D, Guzman G, Raychaudhuri P.
    Mol Cancer Res; 2019 May 28; 17(5):1063-1074. PubMed ID: 30814128
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.
    Wu HY, Luo LF, Wei F, Jiang HM.
    World J Surg Oncol; 2023 Nov 25; 21(1):366. PubMed ID: 38001498
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
    Yang X, Qu K, Tao J, Yin G, Han S, Liu Q, Sun H.
    Biochem Biophys Res Commun; 2018 Jan 08; 495(2):1807-1814. PubMed ID: 29175329
    [Abstract] [Full Text] [Related]

  • 17. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
    Yu M, Tang Z, Meng F, Tai M, Zhang J, Wang R, Liu C, Wu Q.
    Tumour Biol; 2016 Jan 08; 37(1):1289-97. PubMed ID: 26289845
    [Abstract] [Full Text] [Related]

  • 18. FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.
    Li R, Okada H, Yamashita T, Nio K, Chen H, Li Y, Shimakami T, Takatori H, Arai K, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S.
    Int J Mol Sci; 2022 Jul 27; 23(15):. PubMed ID: 35955438
    [Abstract] [Full Text] [Related]

  • 19. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
    Shang R, Pu M, Li Y, Wang D.
    Oncol Rep; 2017 Apr 27; 37(4):2261-2269. PubMed ID: 28260073
    [Abstract] [Full Text] [Related]

  • 20. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene.
    Han M, Lu H, Han K, Yuan X, Liu S, Wang Y, Zhao J, Liang P, Cheng J.
    Biochem Biophys Res Commun; 2019 Jul 30; 515(3):455-461. PubMed ID: 31164201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.